Mayr F, Kruse V, Fuhrmann D, Wolf S, Lober J, Alsouri S
Haematologica. 2023; 109(5):1445-1459.
PMID: 37916396
PMC: 11063853.
DOI: 10.3324/haematol.2023.283663.
Kucukdisli M, Bel-Abed H, Cirillo D, Lo W, Efrem N, Horatscheck A
J Med Chem. 2023; 66(20):14278-14302.
PMID: 37819647
PMC: 11151210.
DOI: 10.1021/acs.jmedchem.3c01319.
Thibault B, Ramos-Delgado F, Guillermet-Guibert J
Cancers (Basel). 2023; 15(3).
PMID: 36765741
PMC: 9913247.
DOI: 10.3390/cancers15030784.
Heng E, Maffucci T
Curr Top Microbiol Immunol. 2022; 436:51-68.
PMID: 36243839
DOI: 10.1007/978-3-031-06566-8_2.
Qin W, Cao L, Massey I
Mol Cell Biochem. 2021; 476(11):4045-4059.
PMID: 34244974
DOI: 10.1007/s11010-021-04219-w.
Class II phosphatidylinositol 3-kinase-C2α is essential for Notch signaling by regulating the endocytosis of γ-secretase in endothelial cells.
Shimizu S, Yoshioka K, Aki S, Takuwa Y
Sci Rep. 2021; 11(1):5199.
PMID: 33664344
PMC: 7933152.
DOI: 10.1038/s41598-021-84548-4.
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects.
Miricescu D, Totan A, Stanescu-Spinu I, Badoiu S, Stefani C, Greabu M
Int J Mol Sci. 2020; 22(1).
PMID: 33375317
PMC: 7796017.
DOI: 10.3390/ijms22010173.
PI(3,4)P2 Signaling in Cancer and Metabolism.
Gozzelino L, De Santis M, Gulluni F, Hirsch E, Martini M
Front Oncol. 2020; 10:360.
PMID: 32296634
PMC: 7136497.
DOI: 10.3389/fonc.2020.00360.
The myotubularin MTMR4 regulates phagosomal phosphatidylinositol 3-phosphate turnover and phagocytosis.
Sheffield D, Jepsen M, Feeney S, Bertucci M, Sriratana A, Naughtin M
J Biol Chem. 2019; 294(45):16684-16697.
PMID: 31543504
PMC: 6851315.
DOI: 10.1074/jbc.RA119.009133.
Antioxidant Effects of Oral Ang-(1-7) Restore Insulin Pathway and RAS Components Ameliorating Cardiometabolic Disturbances in Rats.
Figueiredo V, Barbosa M, de Castro U, Zacarias A, Bezerra F, Guerra de Sa R
Oxid Med Cell Longev. 2019; 2019:5868935.
PMID: 31396301
PMC: 6664692.
DOI: 10.1155/2019/5868935.
Metabolites and Lipids Associated with Fetal Swine Anatomy via Desorption Electrospray Ionization - Mass Spectrometry Imaging.
Leon M, Ferreira C, Eberlin L, Jarmusch A, Pirro V, Rodrigues A
Sci Rep. 2019; 9(1):7247.
PMID: 31076607
PMC: 6510765.
DOI: 10.1038/s41598-019-43698-2.
Class II PI3Ks at the Intersection between Signal Transduction and Membrane Trafficking.
Margaria J, Ratto E, Gozzelino L, Li H, Hirsch E
Biomolecules. 2019; 9(3).
PMID: 30884740
PMC: 6468456.
DOI: 10.3390/biom9030104.
Individual differences in EPA and DHA content of Atlantic salmon are associated with gene expression of key metabolic processes.
Horn S, Sonesson A, Krasnov A, Moghadam H, Hillestad B, Meuwissen T
Sci Rep. 2019; 9(1):3889.
PMID: 30846825
PMC: 6405848.
DOI: 10.1038/s41598-019-40391-2.
Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.
Pemberton J, Balla T
Adv Exp Med Biol. 2018; 1111:77-137.
PMID: 30483964
PMC: 8284841.
DOI: 10.1007/5584_2018_288.
A postsynaptic PI3K-cII dependent signaling controller for presynaptic homeostatic plasticity.
Hauswirth A, Ford K, Wang T, Fetter R, Tong A, Davis G
Elife. 2018; 7.
PMID: 29303480
PMC: 5773188.
DOI: 10.7554/eLife.31535.
PI3K class II α regulates δ-opioid receptor export from the -Golgi network.
Shiwarski D, Darr M, Telmer C, Bruchez M, Puthenveedu M
Mol Biol Cell. 2017; 28(16):2202-2219.
PMID: 28566554
PMC: 5531736.
DOI: 10.1091/mbc.E17-01-0030.
A Critical Role for β-Catenin in Modulating Levels of Insulin Secretion from β-Cells by Regulating Actin Cytoskeleton and Insulin Vesicle Localization.
Sorrenson B, Cognard E, Lee K, Dissanayake W, Fu Y, Han W
J Biol Chem. 2016; 291(50):25888-25900.
PMID: 27777306
PMC: 5207063.
DOI: 10.1074/jbc.M116.758516.
Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.
Alliouachene S, Bilanges B, Chaussade C, Pearce W, Foukas L, Scudamore C
Diabetologia. 2016; 59(7):1503-1512.
PMID: 27138914
PMC: 4901096.
DOI: 10.1007/s00125-016-3963-y.
Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity.
Alliouachene S, Bilanges B, Chicanne G, Anderson K, Pearce W, Ali K
Cell Rep. 2015; 13(9):1881-94.
PMID: 26655903
PMC: 4675724.
DOI: 10.1016/j.celrep.2015.10.052.
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials.
Geuna E, Roda D, Rafii S, Jimenez B, Capelan M, Rihawi K
Br J Cancer. 2015; 113(11):1541-7.
PMID: 26554652
PMC: 4705886.
DOI: 10.1038/bjc.2015.373.